Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Kamal S, Pohar"'
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background UroVysion fluorescence in situ hybridization (uFISH) was reported to have superior sensitivity to urine cytology. However uFISH studies are limited by varying definitions of what is considered a positive result, absence of histopa
Externí odkaz:
https://doaj.org/article/0d4f71f4faca4b72907e30fe6afca8c5
Autor:
Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Kevin Chan, Sam Chang, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman-Censits, Amar Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Vitaly Margulis, Omar Y. Mian, Jeff Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Mamta Parikh, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Kyle Richards, Wade J. Sexton, Arlene O. Siefker-Radtke, Matthew Tollefson, Jonathan Tward, Jonathan L. Wright, Mary A. Dwyer, Carly J. Cassara, Lisa A. Gurski
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:866-878
The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer and other urinary tract cancers (upper tract tumors, urothelial carcinoma of the prostate, primary
Autor:
Sima P. Porten, Max Kates, Heiko Yang, Jeffrey M. Holzbeierlein, Jennifer M. Taylor, Maxwell V. Meng, Brian Willard, Trinity J. Bivalacqua, Siamak Daneshmand, Mark D. Tyson, Badrinath R. Konety, Kamal S. Pohar, Joseph C. Liao, Gary D. Steinberg, Yair Lotan, Hristos Z. Kaimakliotis, Meera Chappidi
Publikováno v:
Journal of Urology. 207:534-540
PURPOSE The utility of blue light cystoscopy (BLC) in patients receiving bacillus Calmette-Guerin (BCG) during post-treatment cystoscopy is not well understood. Our objective was to determine if BLC improves recurrence detection in patients with nonm
Autor:
Kamal S. Pohar, Sima P. Porten, Thomas E. Stout, Subodh Regmi, Badrinath R. Konety, Siamak Daneshmand
Publikováno v:
Urology Practice. 9:94-100
Introduction:Despite the effectiveness of blue light cystoscopy (BLC) in the management of bladder cancer, the adoption of BLC since its approval has been limited. We evaluated the perceive...
Autor:
Yair Lotan, Max Kates, Hristos Z. Kaimakliotis, Hamed Ahmadi, Mark D. Tyson, Kamal S. Pohar, Gary D. Steinberg, Joseph C. Liao, Brian Willard, Sima P. Porten, Seyedeh Sanam Ladi-Seyedian, Jeffrey M. Holzbeierlein, Siamak Daneshmand, Badrinath R. Konety, Jennifer M. Taylor
Publikováno v:
BJU internationalReferences. 130(1)
Objectives To evaluate the role of blue-light cystoscopy (BLC) in detecting invasive tumours that were not visible on white-light cystoscopy (WLC). Patients and methods Using the multi-institutional Cysview registry database, patients who had at leas
Autor:
Siamak Daneshmand, Iris S.G. Brummelhuis, Kamal S. Pohar, Gary D. Steinberg, Manju Aron, Christopher J. Cutie, Kirk A. Keegan, John C. Maffeo, Donald L. Reynolds, Bradley Raybold, Albert Chau, J. Alfred Witjes
Publikováno v:
Urologic Oncology-Seminars and Original Investigations, 40, 344.e1-344.e9
Urologic Oncology-Seminars and Original Investigations, 40, 7, pp. 344.e1-344.e9
Urologic Oncology-Seminars and Original Investigations, 40, 7, pp. 344.e1-344.e9
Contains fulltext : 251844.pdf (Publisher’s version ) (Open Access) OBJECTIVES: Neoadjuvant chemotherapy and radical cystectomy (RC) are underutilized standards of care for the treatment of muscle-invasive bladder cancer (MIBC) due to high patient
Autor:
Kamal S. Pohar, Sanjay Patel, Yair Lotan, Edouard Trabulsi, Michael Woods, Tracy Downs, William C. Huang, Jeffrey Jones, Jennifer Taylor, Michael O'Donnell, Trinity J. Bivalacqua, Joel DeCastro, Gary Steinberg, Ashish M. Kamat, Matthew J. Resnick, Badrinath Konety, Mark Schoenberg, J. Stephen Jones, Siamak Daneshmand
Publikováno v:
Urologic oncology. 40(8)
The therapeutic benefit of intravesical instillation of hexaminolevulinate (HAL) at the time of transurethral resection of bladder tumor (TURBT) has been demonstrated in multiple studies. The purpose of this study was to prospectively assess the safe
Autor:
Kamal S. Pohar
Publikováno v:
Current Urology Reports. 21
It has been firmly established that hexaminolevulinate-assisted blue light cystoscopy (HAL-BLC) reduces cancer recurrence rates. This review explores the impact of HAL-BLC on other meaningful outcomes in patients with bladder cancer, including diseas
Autor:
Hooman Djaladat, Trinity J. Bivalacqua, James P. Tierney, Hamed Ahmadi, Jeffrey M. Holzbeierlein, Sanam Ladi Seyedian, Joseph C. Liao, Badrinath R. Konety, Kamal S. Pohar, Jeniffer Taylor, Anne Schuckman, Sia Daneshmand, Brian Willard
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Blue light cystoscopy (BLC) has been shown to not only increase detection rate of non-muscle invasive bladder cancer (NMIBC) including carcinoma in situ (CIS), it also de...
Autor:
Ashley V. Alford, Subodh Regmi, Arveen Kalapara, Siamak Daneshmand, Sima P. Porten, Badrinath R. Konety, Kamal S. Pohar
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:The use of blue light cystoscopy (BLC) improves the detection of both carcinoma-in-situ and papillary bladder tumors, and is recommended for use in patients with a histor...